Zobrazeno 1 - 10
of 14 400
pro vyhledávání: '"endocrine‐therapy"'
Autor:
Eko Adhi Pangarsa, Putri Dwi Astuti, Daniel Rizky, Kevin Tandarto, Budi Setiawan, Andreas Agung Winarno, Damai Santosa, Catharina Suharti
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-8 (2024)
Abstract Background Metastatic breast cancer especially in disseminated carcinomatosis of bone marrow (DCBM) poses a life-threatening risk, often requiring systemic chemotherapy. This situation lacks a cure, emphasizing symptom relief and quality of
Externí odkaz:
https://doaj.org/article/378541da9a6147068602691b1eed8e6e
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Purpose: Estrogen receptor-positive (ER+), progesterone receptor-negative (PR-) and human epidermal growth factor receptor 2-negative (HER2−) breast cancer (BC) often developed resistance to endocrine treatment (ET). We aimed to explore (1
Externí odkaz:
https://doaj.org/article/f3f1d572d19a46de85fcd98bab7c92cb
Publikováno v:
Journal of Applied Pharmaceutical Research, Vol 12, Iss 5, Pp 16-27 (2024)
Background: Breast cancer is one of the leading causes of cancer-related deaths among women, accounting for 11.7% of all cancer cases and approximately 685,000 deaths worldwide in 2020. Its multifactorial etiology includes genetic, hormonal, and life
Externí odkaz:
https://doaj.org/article/1ac2f17d21294bcfa2ef56b967789e90
Publikováno v:
Zhongguo aizheng zazhi, Vol 34, Iss 10, Pp 972-978 (2024)
Endocrine therapy is the most important adjuvant treatment for early estrogen receptor (ER)-positive breast cancer. ER-low-positive (immunohistochemistry staining 1%-10%) breast cancer has drawn widespread attention in recent years. This group accoun
Externí odkaz:
https://doaj.org/article/2b79745e8a02427e8c31f936fe2725a3
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-10 (2024)
Abstract Objective The objective of this study is to assess the efficacy and safety of combining goserelin with anastrozole in neoadjuvant endocrine therapy (NET) for patients diagnosed with premenopausal breast cancer. Methods A retrospective analys
Externí odkaz:
https://doaj.org/article/ab75bbc867db4da6a0317a2c6433a752
Autor:
Bartomeu Fullana, Serafín Morales, Anna Petit, Ania Alay, Helena Verdaguer, Fina Climent, Valentí Navarro-Perez, Mónica Cejuela, Patricia Galvan, Anna Gumà, Antonio Llombart-Cussac, David Cordero, Oriol Casanovas, Aleix Prat, Miguel Gil-Gil, Sonia Pernas
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Neoadjuvant endocrine therapy (NET) for hormone receptor-positive (HR+) breast cancer might be as effective as chemotherapy, with a better toxicity profile. Blocking a crucial process such as angiogenesis with sunitinib may have a synergisti
Externí odkaz:
https://doaj.org/article/73d2bd5e8b3149adab539c333f43a859
Autor:
Guilherme Nader-Marta, Christian Singer, Dominik Hlauschek, Angela DeMichele, Paolo Tarantino, Evandro de Azambuja, Georg Pfeiler, Miguel Martin, Justin M. Balko, Zbigniew Nowecki, Marija Balic, Adam M. Brufsky, Arlene Chan, Patrick G. Morris, Tufia Haddad, Sibylle Loibl, Yuan Liu, Lidija Soelkner, Christian Fesl, Erica L. Mayer, Michael Gnant, on behalf of the PALLAS groups and investigators
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-10 (2024)
Abstract Background Bidirectional crosstalk between HER2 and estrogen receptor (ER) pathways may influence outcomes and the efficacy of endocrine therapy (ET). Low HER2 expression levels (HER2-low) have emerged as a predictive biomarker in patients w
Externí odkaz:
https://doaj.org/article/c4f4965043a847fba7a786c64cdbe554
Publikováno v:
Current Oncology, Vol 31, Iss 10, Pp 5873-5888 (2024)
(1) Background: While there is extensive documentation on the medical experience of breast cancer, a thorough understanding of the various stages of endocrine therapy remains insufficient. The aim of this study was to map the experiences and coping s
Externí odkaz:
https://doaj.org/article/062d4a42ad9c42948fef7555201297b2
Autor:
Ran Ran, Shidi Zhao, Yan Zhou, Xinyue Hang, Hui Wang, Yuan Fan, Yusi Zhang, Yifan Qiao, Jin Yang, Danfeng Dong
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-17 (2024)
Abstract Background Different hormone receptor (HR) expression patterns have significant biological and therapeutic implications in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer. However, the distinction between
Externí odkaz:
https://doaj.org/article/c62db2b92ea6485b8eea8eb9f1be7b12
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-5 (2024)
Abstract Background Breast cancer is the most common cancer in women. Progression-free survival for hormone receptor-positive/human epidermal growth factor receptor-2-negative metastatic breast cancer treated with endocrine therapy in combination wit
Externí odkaz:
https://doaj.org/article/22f8c3121cd24a848570b640a455bd4c